The Glycine Site on the NMDA Receptor: Pharmacology and Involvement in NMDA Receptor-Mediated Neurodegeneration
- 1 January 1990
- book chapter
- Published by Springer Nature
- Vol. 268, 93-100
- https://doi.org/10.1007/978-1-4684-5769-8_11
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- HA-966 antagonizes N-methyl-D-aspartate receptors through a selective interaction with the glycine modulatory siteJournal of Neuroscience, 1989
- Antagonist profile of 6,7-dichloro-3-hydroxy-2-quinoxalinecarboxylate at excitatory amino acid receptors in the neonatal rat spinal cordEuropean Journal of Pharmacology, 1989
- Glycine maintains excitementNature, 1989
- Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activationJournal of Neuroscience, 1988
- 6,7-Dinitro-quinoxaline-2,3-dion and 6-nitro,7-cyano-quinoxaline-2,3-dion antagonise responses to NMDA in the rat spinal cord via an action at the strychnine-insensitive glycine receptorEuropean Journal of Pharmacology, 1988
- Glycine reverses antagonism of N-methyl-D-aspartate (NMDA) by 1-hydroxy-3-aminopyrrolidone-2 (HA-966) but not by D-2-amino-5-phophonovalerate (D-AP5) on rat cortical slicesEuropean Journal of Pharmacology, 1988
- Biochemical evidence that glycine allosterically regulates an NMDA receptor-coupled ion channelEuropean Journal of Pharmacology, 1987
- Taking apart NMDA receptorsNature, 1987
- Light microscopic autoradiographic localisation of [3H]glycine and [3H]strychnine binding sites in rat brainEuropean Journal of Pharmacology, 1986
- Is 1-Hydroxy-3-aminopyrrolidone-2 (HA-966) a Selective Excitatory Amino-acid Antagonist?Nature New Biology, 1972